Ceryvyn Therapeutics Ltd. - Unsponsored ADR (CYVNY) vs VectivBio Holding AG (VECT)

Ceryvyn Therapeutics Ltd. - Unsponsored ADR and VectivBio Holding AG are both Biotechnology companies. Ceryvyn Therapeutics Ltd. - Unsponsored ADR and VectivBio Holding AG are of similar size ($545.5M and $524.8M). VectivBio Holding AG has the higher net margin (0.00% vs −89,724.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, Ceryvyn Therapeutics Ltd. - Unsponsored ADR leads on 5 and VectivBio Holding AG on 4.

Valuation

Metric CYVNY VECT Biotechnology median
P/E n/m n/m 7.88
P/S 2.37 n/m 11.47
P/B n/m 3.94 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 759.28 n/m 10.73
Earnings yield (2,375.00%) (27.42%) (28.84%)
Free cash flow yield (84,379.36%) (21.00%) (23.03%)

Profitability

Metric CYVNY VECT Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin (89,724.18%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (147.18%) (57.72%)
Return on assets 0.00% (111.86%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CYVNY VECT Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 61.59% 34.37% —
Revenue growth, 5-year CAGR (15.81%) — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CYVNY VECT Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 0.22 9.14 4.73
Net debt to EBITDA 0.31 2.63 0.96

Dividend

Metric CYVNY VECT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CYVNY VECT Biotechnology median
Market cap 524.83m 545.50m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack